NIM
RCKT icon

NEOS Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

NEOS Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,030
Closed -$78.5K – 647
2025
Q2 		$78.5K Sell
32,030
-4,833
-13% -$24.5K ﹤0.01% 614
2025
Q1 		$246K Sell
36,863
-54,122
-59% -$535K ﹤0.01% 572
2024
Q4 		$1.14M Sell
90,985
-20,469
-18% -$308K 0.03% 382
2024
Q3 		$2.06M Buy
111,454
+8,607
+8% +$176K 0.06% 258
2024
Q2 		$2.21M Buy
102,847
+45,247
+79% +$1.04M 0.09% 201
2024
Q1 		$1.55M Buy
57,600
+38,080
+195% +$1.08M 0.1% 197
2023
Q4 		$585K Buy
+19,520
New +$431K 0.06% 254

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return